Search research articles
Contact Us
Filters
Showing results (41-50 of 176) with videos related to
Page
of 18
Sort By:
Journal for Immunotherapy of Cancer
|
July 19, 2017
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
James L Gulley, Elizabeth A Repasky, Laura S Wood, et al.
Oncoimmunology
|
May 12, 2015
Molecular mimicry of MAGE-A6 and <i>Mycoplasma penetrans</i> HF-2 epitopes in the induction of antitumor CD8<sup>+</sup> T-cell responses
Lazar Vujanovic, Jian Shi, John M Kirkwood, et al.
Oncoimmunology
|
July 4, 2012
Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10
Lazar Vujanovic, Wenners Ballard, Stephen H Thorne, et al.
Journal for Immunotherapy of Cancer
|
March 21, 2023
Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch <i>et al</i>
Zinal S Chheda, Sabine Mueller, Bindu Hegde, et al.
Journal for Immunotherapy of Cancer
|
July 21, 2016
Cancer immunotherapy trials: leading a paradigm shift in drug development
Leisha A Emens, Lisa H Butterfield, F Stephen Hodi, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2015
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
Lisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal of Immunological Methods
|
January 3, 2012
Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients
Douglas M Potter, Lisa H Butterfield, Sherrie J Divito, et al.
Cancer Immunology, Immunotherapy : CII
|
May 20, 2008
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus
Lazar Vujanovic, Theresa L Whiteside, Douglas M Potter, et al.
CA: a Cancer Journal for Clinicians
|
May 12, 2012
Immunotherapy of cancer in 2012
John M Kirkwood, Lisa H Butterfield, Ahmad A Tarhini, et al.
Journal of Translational Medicine
|
December 9, 2010
Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force
Lisa H Butterfield, Mary L Disis, Samir N Khleif, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 176) with videos related to
Sort By:
Page
of 18
Journal for Immunotherapy of Cancer
|
July 19, 2017
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
James L Gulley, Elizabeth A Repasky, Laura S Wood, et al.
Oncoimmunology
|
May 12, 2015
Molecular mimicry of MAGE-A6 and <i>Mycoplasma penetrans</i> HF-2 epitopes in the induction of antitumor CD8<sup>+</sup> T-cell responses
Lazar Vujanovic, Jian Shi, John M Kirkwood, et al.
Oncoimmunology
|
July 4, 2012
Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10
Lazar Vujanovic, Wenners Ballard, Stephen H Thorne, et al.
Journal for Immunotherapy of Cancer
|
March 21, 2023
Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch <i>et al</i>
Zinal S Chheda, Sabine Mueller, Bindu Hegde, et al.
Journal for Immunotherapy of Cancer
|
July 21, 2016
Cancer immunotherapy trials: leading a paradigm shift in drug development
Leisha A Emens, Lisa H Butterfield, F Stephen Hodi, et al.
Journal for Immunotherapy of Cancer
|
March 26, 2015
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
Lisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
Journal of Immunological Methods
|
January 3, 2012
Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients
Douglas M Potter, Lisa H Butterfield, Sherrie J Divito, et al.
Cancer Immunology, Immunotherapy : CII
|
May 20, 2008
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus
Lazar Vujanovic, Theresa L Whiteside, Douglas M Potter, et al.
CA: a Cancer Journal for Clinicians
|
May 12, 2012
Immunotherapy of cancer in 2012
John M Kirkwood, Lisa H Butterfield, Ahmad A Tarhini, et al.
Journal of Translational Medicine
|
December 9, 2010
Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force
Lisa H Butterfield, Mary L Disis, Samir N Khleif, et al.
Page
of 18